TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial.

Marisa Holubar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.